High-normal blood pressure and future risks - a new concern for clinicians?

被引：2

作者：

Nilsson, Peter M. ^{[1
]}

机构：

[1] Lund Univ, Univ Lund Hosp, Dept Clin Sci Med, S-20502 Malmo, Sweden

来源：

EUROPEAN HEART JOURNAL | 2007年 / 28卷 / 23期

关键词：

D O I：

10.1093/eurheartj/ehm494

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：2832 / 2833

页数：2

共 12 条

[1]

Grundy Scott M, 2005, Crit Pathw Cardiol, V4, P198

[2] Acarbose for prevention of type 2 diabetes mellitus: the STOPNIDDM randomised trial [J].

Chiasson, JL ;

Josse, RG ;

Gomis, R ;

Hanefeld, M ;

Karasik, A ;

Laakso, M .

LANCET, 2002, 359 (9323) :2072-2077

[3] Blood pressure and risk of developing type 2 diabetes mellitus: The Women's Health Study [J].

Conen, David ;

Ridker, Paul M. ;

Mora, Samia ;

Buring, Julie E. ;

Glynn, Robert J. .

EUROPEAN HEART JOURNAL, 2007, 28 (23) :2937-2943

[4] Risk of cardiovascular events among women with high normal blood pressure or blood pressure progression: prospective cohort study [J].

Conen, David ;

Ridker, Paul M. ;

Buring, Julie E. ;

Glynn, Robert J. .

BMJ-BRITISH MEDICAL JOURNAL, 2007, 335 (7617) :432-436B

[5]

Franklin SS, 1997, CIRCULATION, V96, P308

[6] Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose:: a randomised controlled trial [J].

Gerstein, H. C. ;

Yusuf, S. ;

Holman, R. R. ;

Bosch, J. ;

Anand, S. ;

Avezum, A. ;

Budaj, A. ;

Chiasson, J. ;

Conget, I. ;

Dagenais, G. ;

Davis, M. ;

Diaz, R. ;

Dinccag, N. ;

Enjalbert, M. ;

Escalante, A. ;

Fodor, G. ;

Hanefeld, M. ;

Hedner, T. ;

Jolly, K. ;

Keltai, M. ;

Laakso, M. ;

Lanas, F. ;

Lonn, E. ;

McQueen, M. ;

Mohan, V. ;

Phillips, A. ;

Piegas, L. ;

Pirags, V. ;

Probstfield, J. ;

Shaw, J. ;

Schmid, I. ;

Teo, K. ;

Zimmet, P. ;

Zinman, B. ;

Gerstein, H. C. ;

Yusuf, S. ;

Bosch, J. ;

Pogue, J. ;

Sheridan, P. ;

Dinccag, N. ;

Hanefeld, M. ;

Hoogwerf, B. ;

Laakso, M. ;

Mohan, V. ;

Shaw, J. ;

Zinman, B. ;

Holman, R. R. ;

Diaz, R. ;

Ahuad Guerrero, R. ;

Albisu, J. .

LANCET, 2006, 368 (9541) :1096-1105

[7] European guidelines on cardiovascular disease prevention in clinical practice: executive summary [J].

Graham, Ian ;

Atar, Dan ;

Borch-Johnsen, Knut ;

Boysen, Gudrun ;

Burell, Gunilla ;

Cifkova, Renata ;

Dallongeville, Jean ;

De Backer, Guy ;

Ebrahim, Shah ;

Gjelsvik, Bjorn ;

Herrman-Lingen, Christoph ;

Hoes, Arno ;

Humphries, Steve ;

Knapton, Mike ;

Perk, Joep ;

Priori, Silvia G. ;

Pyorala, Kalevi ;

Reiner, Zeljko ;

Ruilope, Luis ;

Sans-Menendez, Susana ;

Reimer, Wilma Scholte op ;

Weissberg, Peter ;

Wood, David ;

Yarnell, John ;

Zamorano, Jose Luis .

EUROPEAN HEART JOURNAL, 2007, 28 (19) :2375-2414

[8] Feasibility of treating prehypertension with an angiotensin-receptor blocker [J].

Julius, S ;

Nesbitt, SD ;

Egan, BM ;

Weber, MA ;

Michelson, EL ;

Kaciroti, N ;

Black, HR ;

Grimm, RH ;

Messerli, FH ;

Oparil, S ;

Schork, MA .

NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (16) :1685-1697

[9]

Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512

[10] Mechanisms by which common variants in the TCF7L2 gene increase risk of type 2 diabetes [J].

Lyssenko, Valeriya ;

Lupi, Roberto ;

Marchetti, Piero ;

Del Guerra, Silvia ;

Orho-Melander, Marju ;

Almgren, Peter ;

Sjogren, Marketa ;

Ling, Charlotte ;

Eriksson, Karl-Fredrik ;

Lethagen, Asa-Linda ;

Mancarella, Rita ;

Berglund, Goran ;

Tuomi, Tiinamaija ;

Nilsson, Peter ;

Del Prato, Stefano ;

Groop, Leif .

JOURNAL OF CLINICAL INVESTIGATION, 2007, 117 (08) :2155-2163

← 1 2 →